โ† All Topics / ade

FDA ADE reports for Rabacfosadine Succinate

ade_rabacfosadine_adverse_events

ade en 2026-07-22

Rabacfosadine Succinate โ€” FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Rabacfosadine Succinate is a active ingredient.

Total reports

Rabacfosadine Succinate: 341

Reports by species (top entries)

  • Dog 338
  • Cat 1
  • Human 1
  • Other Mammals 1

Top reported reactions (VEDDRA terms, top entries)

  • Anorexia 109
  • Diarrhoea 99
  • Lethargy (see also Central nervous system depression in 'Neurological') 88
  • Death by euthanasia 75
  • Weight loss 75
  • Lack of efficacy - NOS 68
  • Elevated liver enzymes 46
  • Neutropenia 45
  • Alopecia 40
  • Vomiting 40

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b16.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).